pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
Mydayis ER
Mydayis ((amphetamine aspartate + amfetamine [INN] + dextroamphetamine saccharate + dextroamphetamine sulfate))
Attention Deficit Hyperactivity Disorder (ADHD)
Takeda Pharmaceuticals USA Inc
Phase 2
Mydicar
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
Marketed
Myezom
Bortezomib
Mantle Cell Lymphoma
Dr. Reddy's Laboratories Ltd
Preclinical
← prev
page 128 of 271
next →
Pain
89
Neurology
1
MyoDys45-55
Duchenne Muscular Dystrophy
MyoGene Bio LLC
Phase 1
MyoPAXon
Duchenne Muscular Dystrophy
Myogenica Inc
Preclinical
N-0651
Age Related Macular Degeneration
Naegis Pharmaceuticals Inc
pre_registration
N-115
Chronic Obstructive Pulmonary Disease (COPD)
EmphyCorp Inc
phase_0
N-acetyl cysteine
Traumatic Brain Injury
Neuronasal LLC
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
N/A
N/A (ATROPINE INJECTION, 2 MG)
no indication
RAFA LABS LTD
Phase 2
NA-704
Amyotrophic Lateral Sclerosis
Biomed Industries Inc
Phase 1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
Phase 3
NA-831
Traneurocin
Alzheimer's Disease
Biomed Industries Inc
Phase 3
NA-921
Rett Syndrome
Biomed Industries Inc
Phase 2
NA-931
Obesity
Biomed Industries Inc
Phase 3
NA-941
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Biomed Industries Inc
Preclinical
NAFL Diseases
Metabolic Dysfunction-Associated Steatotic Liver Disease…
Metallomix Inc
NALMEFENE HYDROCHLORIDE
NALMEFENE HYDROCHLORIDE
no indication
Purdue Pharma LP
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)
no indication
Lupin Ltd
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
no indication
Ajanta Pharma Ltd
NAPROXEN ORAL SUSPENSION
NAPROXEN ORAL SUSPENSION (NAPROXEN ORAL)
no indication
NOVITIUM PHARMA
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL
NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL
no indication
GRANULES
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
Phase 2
NB-001
DiGeorge Syndrome
Nobias Therapeutics Inc
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
Preclinical
NBIB-233
Parkinson's Disease
$VYGR
Voyager Therapeutics, Inc.
Preclinical
NBIP-2118
Obesity
$NBIX
NEUROCRINE BIOSCIENCES INC
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
Phase 1
NC-2400
Dyslipidemia
ABIONYX Pharma SA
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
